(CIDRAP News) –Two vaccine companies, Sanofi Pasteur and GlaxoSmithKline, recently announced they received their first orders from the US government for a vaccine and adjuvant to protect the country against the novel H1N1 virus.
May 22, 2009
May 20, 2009
(CIDRAP News) A new report from a World Health Organization (WHO) advisory group predicts that global production of vaccine for the novel H1N1 influenza virus could be as much as 4.9 billon doses a year, far higher than previous estimates.
May 14, 2009
(CIDRAP News) –The US Food and Drug Administration (FDA) today announced approval of a new influenza vaccine manufacturing facility in Pennsylvania that could be used to produce a vaccine against the novel influenza H1N1 (swine flu) virus.
(CIDRAP News) The World Health Organization (WHO) will convene a group of experts May 14 to advise the agency on whether to pull the trigger on production of a vaccine for the novel H1N1 swine influenza virus, a WHO official announced today.
(CIDRAP News) National and international health authorities said today that they have begun the first steps in manufacturing a vaccine against the novel H1N1 swine influenza, though they appeared to disagree over whether full-scale manufacturing will move forward.
(CIDRAP News) Swine influenza viruses have never been documented as the cause of a human influenza pandemic, but in 1976 they generated pandemic fears strong enough to trigger a nationwide vaccination campaign.
The reporting of swine flu cases in two California children this week stirred memories of the 1976 episode, which caused major embarrassment for public health authorities when the pandemic never materialized.
Apr 20, 2009
